Floatz logo

Sovateltide

Cerebral Ischemia

Pharmazz, Inc.protein_peptidePhase 3Dormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Cerebral Ischemia cohort.

Asset / SponsorPhaseRating
Dipyridamole
UMC Utrecht
Phase 4BB
Acetylsalicylic Acid
City Clinical Hospital No. 67, Moscow, Russia
Phase 4BB
Lacosamide
University of North Carolina, Chapel Hill
Phase 4BB
3-N-BUTYLPHTHALIDE
Qianfoshan Hospital
Phase 4BB
Probucol
Asan Medical Center
Phase 4BB

View all 36 →

Same molecule, other indications

Sovateltide is also rated in:

cerebral infarctionDormant
BBB
Indicative ·
75 / 100
View asset →
stroke disorderDormant
BB
Indicative ·
67 / 100
View asset →
stroke disorderDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →